Galderma has officially announced the appointment of Luigi La Corte as its new Chief Financial Officer (CFO). He will join the executive leadership team on May 1, 2026. This transition follows the departure of Thomas Dittrich, who served in the role since 2019.
The company is a world leader in the dermatology area. The addition of an experienced Chief Financial Officer (CFO) is critical to the long-term plan. Mr. La Corte has more than 30 years of experience from different global healthcare companies.
Strategic Leadership in Dermatology
The new appointee previously held senior roles at companies like Recordati and GSK. His background includes significant experience in the pharmaceutical and consumer sectors. Consequently, he understands the financial needs of large-scale medical businesses.
Galderma remains focused on its pure-play dermatology portfolio. This leadership change ensures continuity in its financial operations. Furthermore, the firm continues to grow across all product categories.
Flemming Ørnskov, M.D., MPH, CEO of Galderma, stated:
“Luigi La Corte is an accomplished financial leader with deep experience across global healthcare and consumer organizations. I am delighted to welcome him to the Executive Committee and look forward to working with him closely as we continue to execute our Integrated Dermatology Strategy.”
The outgoing leader will support a smooth transition over the coming months. Accuracy regarding the transition period remains a priority for the firm. As a result, the incoming Chief Financial Officer (CFO) will maintain the company’s momentum.
Investors and stakeholders can expect a seamless handover of duties through Q2 2026. The company maintains a strong financial position during this transition. This appointment marks a significant step for the Swiss-based organization.
Explore Finance Tech News for the latest innovations in financial technologies and expert insights shaping the future of digital finance!
News Source: Businesswire.com
